11
Growth Score
pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Approaches towards Bone diseases
About the Company
Therosteon is a new biotech fledgling emerging from the Erasmus Medical Center in Rotterdam (The Netherlands). The Company develops novel therapeutics for bone diseases including osteoporosis, osteoarthritis, and bone metastasis based on its OsteoBLAST technology platform.
Bone diseases represent an interesting market opportunity, with huge
unmet medical needs. Osteoporosis in itself represents a huge market opportunity with drug sales totaling 7 billion.
Therosteon is located in incubator facilities of the Erasmus MC and collaborates closely with academic group of its scientific founder Prof. Hans van Leeuwen.
